Amarin (AMRN) has a profit margin of -17.67%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
Amarin (AMRN) currently reports a profit margin of -17.67% as of June 2026. That compares with -54.01% in the prior-year period — up 67.3% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Amarin's profit margin history and peer comparisons.
Amarin's profit margin increased from -54.01% to -17.67% — a 67.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Amarin's profit margin of -17.67% is lower than the Healthcare sector average of 21.34%. That is roughly 182.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Amarin's current -17.67% should be judged against Healthcare norms (sector average: 21.34%) and against AMRN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -17.67%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Amarin, and consider following AMRN for alerts when major investors trade the stock.